David M. Mcintosh serves as Executive at REXAHN PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, David M. Mcintosh has executed 4 insider transactions totaling $4.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 14, 2014 involved exercising options for 125,000 shares valued at $100.0K.
David M. Mcintosh currently holds 125,000 shares of REXAHN PHARMACEUTICALS, INC. (RNN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David M. Mcintosh has been a net buyer of RNN stock. They have purchased $4.5K and sold $0 worth of shares.
David M. Mcintosh's most recent insider trade was on Apr 14, 2014, when they sold 125,000 shares at $0.80 per share.
Get notified when new Form 4 filings are submitted
| 99,010 |
| $1.01 |
| Discretionary |
| Jul 30, 2009 | RNN | $2.2K | Purchase | 2,800 | $0.80 | Discretionary |
| Jul 30, 2009 | RNN | $2.2K | Purchase | 2,800 | $0.80 | Discretionary |